ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,421.77
      0.13%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Spyre Therapeutics Inc (SYRE)

      7. Spyre Therapeutics Inc (SYRE) News

      SYRE Spyre Therapeutics Inc

      33.67
      -0.94 (-2.72%)
      Jun 07 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Spyre Therapeutics Inc SYRE NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.94 -2.72% 33.67 17:51:37
      Open Price Low Price High Price Close Price Prev Close
      34.89 33.09 35.20 33.67 34.61
      more quote information »

      Recent News

      Date Time Source Heading
      6/03/202417:23PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
      5/30/202416:33EDGAR2Form 8-K - Current report
      5/29/202408:30PRNUSSpyre Therapeutics to Participate in the Jefferies Global..
      5/16/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/16/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/16/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/16/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/16/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/16/202416:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
      5/15/202407:40EDGAR2Form 8-K - Current report
      5/15/202407:30PRNUSSpyre Therapeutics Appoints Accomplished Biopharma Leader..
      5/09/202416:11EDGAR2Form 8-K - Current report
      5/09/202416:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      5/09/202416:02PRNUSSpyre Therapeutics Reports First Quarter 2024 Financial..
      5/03/202417:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
      4/01/202417:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
      3/18/202408:00PRNUSSpyre Therapeutics Announces $180 Million Private Placement
      3/05/202417:15EDGAR2Form POS AM - Post-Effective amendments for registration..
      3/01/202417:25PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
      3/01/202406:14EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
      2/29/202417:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/29/202416:14EDGAR2Form 8-K - Current report
      2/29/202416:05PRNUSSpyre Therapeutics Reports Fourth Quarter and Full Year 2023..
      2/26/202407:30PRNUSSpyre Therapeutics to Participate in the 44th Annual TD..
      2/20/202421:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/14/202420:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202416:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202415:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202408:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/13/202418:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/13/202416:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/08/202407:30PRNUSSpyre Therapeutics Announces Three Abstracts Accepted for..
      2/05/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/05/202417:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
      2/05/202407:36EDGAR2Form 8-K - Current report
      2/05/202407:30PRNUSSpyre Therapeutics Appoints Accomplished Biopharma and IBD..
      2/02/202420:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202420:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:30PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
      1/18/202416:26EDGAR2Form 8-K - Current report
      12/29/202317:00EDGAR2Form SC 13D/A - General statement of acquisition of..
      12/29/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/26/202321:56EDGAR2Form D - Notice of Exempt Offering of Securities
      12/22/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202317:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
      12/22/202317:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
      12/22/202316:32EDGAR2Form S-1 - General form for registration of securities under..
      12/11/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202317:21EDGAR2Form SC 13D/A - General statement of acquisition of..

      Your Recent History

      NASDAQ
      SYRE
      Spyre Therapeutics
      Delayed Upgrade Clock